📱 Now on iPhone — live scores, valuations & alerts on the go
1 free score card remaining
Arcus Biosciences, Inc. (RCUS)
Healthcare
Model Divergence
weak
$23.75
Updated: 2026-10-18
42
TradeApes Score
Financial Strength
38
Weak
Operating Trend
64
Healthy
Relative Value
16
Overvalued
Capital Allocation
7
Stressed
Risk Management
55
Mixed
Sector Rank
#6787
The market price implies growth our normalized base can't support, so we don't publish a single fair-value figure for RCUS.
Key Findings
+
operating-margin trend + inflection
−
FCF margin + growth
Industry Related Stocks
Get RCUS and 3,000+ stocks in your pocket
Health scores, fair-value estimates, and full company analysis — free on iPhone.
Download iPhone App
TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor.
The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.
Sign up for our Weekly Sector Leaders Newsletter
11 sector-leading stocks delivered to your inbox every Sunday. Free.
No spam. Unsubscribe anytime.